BGM-innovativ - Workplace, cross-provider Healthcare management of company health insurance funds
- Conditions
- M00-M99Diseases of the musculoskeletal system and connective tissue
- Registration Number
- DRKS00015120
- Lead Sponsor
- IMVR - Institut für Medizinsoziologie, Versorgungsforschung und Rehabilitationswissenschaft, Humanwissenschaftliche Fakultät und Medizinische Fakultät, Universität zu Köln
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 852
General inclusion criteria:
M-diagnosis (ICD-10) with or without inability to work, principal ability to work, member of one the participating company health insurance funds
Additionally, depending on module:
Module A: Employees with beginning musculoskeletal condition, diagnosed, beginning functional restrictions, no or low rate of absent days (up to 14 days), not suitable for medical rehabilitation according to DRV
Module B: criteria according to DRV for medical rehabilitation fulfilled (§26 SGB IX), pronounced incapacity to work (frequent short absence rates or absent rates up to 4 weeks),
Module C: employee with severe musculoskeletal disorders, severe condition, potentially threathened job loss, reintegration in question, possibly comorbidities, long absent rates (more than 6 weeks).
not suitable for rehabilitation (concerning Module B and C), M-diagnosis M00.0-00.9, M01.0-01.8, M02.0-02.9, M03.0-03.6, M08.0-08.9, M09.0- 09.8, M20.0-20.6, M30-36, M46.0-46.9, M60.0-60.9, M61.0-61.9, M62.0-62.9, M63.0- 63.8, M80.0-80.9, M84.0-84.9, M87.0-87.9, M88.0-M88.9, M90.0-90.8
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method workability (Workability-Index) and absent days at work (routine data delivered by participating company health insurance funds)<br><br>Study participants receive a standardized questionnaire directly after informed consent (baseline) and after intervention (approx. 6 months)<br>
- Secondary Outcome Measures
Name Time Method quantitative:<br>pain (Deutscher Schmerzfragebogen) <br>self-efficacy (Skala zur Allgemeinen Selbstwirksamkeitserwartung), exploratie Analysis of additional outcomes (e.g. functional tests) <br><br>qualitative:<br>focus group discussion with case managers and expert interviews with company physicians
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.